Virchows Arch. 2023 Jan;482(1):227-244. doi: 10.1007/s00428-022-03414-4. Epub 2022 Oct 11.
PMID:36216980
Mature B, T and NK-cell, plasma cell and histiocytic/dendritic cell neoplasms: classification according to the World Health Organization and International Consensus Classification.
Central Nervous System Progression/Relapse in Mature T- and NK-Cell Lymphomas.
Bhansali RS, Barta SK.
Cancers (Basel). 2023 Feb 1;15(3):925. doi: 10.3390/cancers15030925.
PMID:36765882
Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study.
Bachy E, Savage KJ, Huang H, Kwong YL, Gritti G, Zhang Q, Liberati AM, Cao J, Yang H, Hao S, Hu J, Zhou K, Petrini M, Russo F, Zhang H, Sang W, Ji J, Ferreri AJM, Damaj GL, Liu H, Zhang W, Ke X, Ghiggi C, Huang S, Li X, Yao H, Paik J, Novotny W, Zhou W, Zhu H, Zinzani PL.
Blood Adv. 2023 Aug 22;7(16):4435-4447. doi: 10.1182/bloodadvances.2022009575.
PMID:37276067
Mature T- and NK-cell non-Hodgkin lymphoma in children and young adolescents.